Table 3.

Conditions of gadoterate meglumine administration per age class (Safety population; N = 1629).

	n (%) patients per age class
	<2 yearsn = 106	2 to <12 yearsn = 814	12 to <18 yearsn = 709	Totaln = 1629
Dose (mL/kg)
Mean (SD)	0.34 (0.37)	0.24 (0.12)	0.21 (0.07)	0.24 (0.14)
Median	0.20	0.21	0.20	0.20
Min–Max	0.1–2.1	0.1–1.7	0.0–0.9	0.0–2.1
Dose (mL/kg) in class
<0.18 mL/kg	18 (17.1%)	160 (20.0%)	150 (21.4%)	328 (20.4%)
0.18 to 0.22 mL/kg	47 (44.8%)	335 (41.8%)	348 (49.6%)	730 (45.4%)
>0.22 to 0.66 mL/kg	30 (28.6%)	300 (37.4%)	203 (28.9%)	533 (33.1%)
>0.66 mL/kg	10 (9.5%)	7 (0.9%)	1 (0.1%)	18 (1.1%)
Missing	1	12	7	20

SD: Standard deviation.

Percentages are calculated on number of available data for classes of doses.